# Franklin BSP Capital Corp: financial statements, quarterly

FRBP · OTC · CIK 1825248 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frbp.md) · [Financials](/companies/frbp/financials.md) · [Filings](/companies/frbp/filings.md) · [Insiders](/companies/frbp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frbp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [7.8](/filings/0001825248-23-000014.md) | [7.7 d](/filings/0001825248-24-000007.md) | [22.9](/filings/0001825248-24-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [15.0](/filings/0001825248-24-000018.md) | [7.7 d](/filings/0001825248-26-000007.md) | [26.2](/filings/0001825248-25-000008.md) | [32.9](/filings/0001825248-25-000017.md) | [30.5](/filings/0001825248-25-000022.md) | [(0.4) d](/filings/0001825248-26-000007.md) | [24.9](/filings/0001825248-26-000017.md) | [26.2](/filings/0001825248-26-000024.md) | [24.3](/filings/0001825248-25-000022.md) | [29.0 d](/filings/0001825248-26-000007.md) | [18.5](/filings/0001825248-26-000017.md) | [26.5](/filings/0001825248-26-000024.md) |
| Diluted EPS | $ per share | [0.49](/filings/0001825248-24-000018.md) | not reported | [0.24](/filings/0001825248-25-000008.md) | [0.23](/filings/0001825248-25-000017.md) | [0.21](/filings/0001825248-25-000022.md) | not reported | [0.17](/filings/0001825248-26-000017.md) | [0.18](/filings/0001825248-26-000024.md) | [0.17](/filings/0001825248-25-000022.md) | not reported | [0.13](/filings/0001825248-26-000017.md) | [0.19](/filings/0001825248-26-000024.md) |
| Basic EPS | $ per share | [0.49](/filings/0001825248-24-000018.md) | not reported | [0.24](/filings/0001825248-25-000008.md) | [0.23](/filings/0001825248-25-000017.md) | [0.21](/filings/0001825248-25-000022.md) | not reported | [0.17](/filings/0001825248-26-000017.md) | [0.18](/filings/0001825248-26-000024.md) | [0.17](/filings/0001825248-25-000022.md) | not reported | [0.13](/filings/0001825248-26-000017.md) | [0.19](/filings/0001825248-26-000024.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [70.0](/filings/0001825248-24-000018.md) | [48.5](/filings/0001825248-26-000007.md) | [96.4](/filings/0001825248-25-000008.md) | [64.6](/filings/0001825248-25-000017.md) | [135](/filings/0001825248-25-000022.md) | [119](/filings/0001825248-26-000007.md) | [190](/filings/0001825248-26-000017.md) | [105](/filings/0001825248-26-000024.md) | [109](/filings/0001825248-25-000022.md) | [101](/filings/0001825248-26-000024.md) | [73.2](/filings/0001825248-26-000017.md) | [35.4](/filings/0001825248-26-000024.md) |
| Total assets | $m | [859](/filings/0001825248-23-000014.md) | [832](/filings/0001825248-25-000004.md) | [3,664](/filings/0001825248-24-000011.md) | [3,716](/filings/0001825248-24-000014.md) | [4,035](/filings/0001825248-24-000018.md) | [4,169](/filings/0001825248-26-000007.md) | [4,177](/filings/0001825248-25-000008.md) | [4,290](/filings/0001825248-25-000017.md) | [4,308](/filings/0001825248-25-000022.md) | [4,248](/filings/0001825248-26-000024.md) | [4,192](/filings/0001825248-26-000017.md) | [4,170](/filings/0001825248-26-000024.md) |
| Total liabilities | $m | [391](/filings/0001825248-23-000014.md) | [366](/filings/0001825248-25-000004.md) | [1,588](/filings/0001825248-24-000011.md) | [1,684](/filings/0001825248-24-000014.md) | [2,011](/filings/0001825248-24-000018.md) | [2,181](/filings/0001825248-26-000007.md) | [2,200](/filings/0001825248-25-000008.md) | [2,359](/filings/0001825248-25-000017.md) | [2,387](/filings/0001825248-25-000022.md) | [2,330](/filings/0001825248-26-000024.md) | [2,283](/filings/0001825248-26-000017.md) | [2,302](/filings/0001825248-26-000024.md) |
| Long-term debt | $m | [342](/filings/0001825248-23-000014.md) | [320](/filings/0001825248-25-000004.md) | [1,479](/filings/0001825248-24-000011.md) | [1,579](/filings/0001825248-24-000014.md) | [1,895](/filings/0001825248-24-000018.md) | [2,055](/filings/0001825248-26-000007.md) | [2,122](/filings/0001825248-25-000008.md) | [2,281](/filings/0001825248-25-000017.md) | [2,304](/filings/0001825248-25-000022.md) | [2,245](/filings/0001825248-26-000024.md) | [2,189](/filings/0001825248-26-000017.md) | [2,199](/filings/0001825248-26-000024.md) |
| Short-term borrowings | $m | [0.0](/filings/0001825248-23-000014.md) | [0.0](/filings/0001825248-25-000004.md) | [0.0](/filings/0001825248-24-000011.md) | [0.0](/filings/0001825248-24-000014.md) | [0.0](/filings/0001825248-24-000018.md) | [0.0](/filings/0001825248-26-000007.md) | [0.0](/filings/0001825248-25-000008.md) | [0.0](/filings/0001825248-25-000017.md) | [0.0](/filings/0001825248-25-000022.md) | [0.0](/filings/0001825248-26-000024.md) | [0.0](/filings/0001825248-26-000017.md) | [0.0](/filings/0001825248-26-000024.md) |
| Shareholders' equity | $m | [391](/filings/0001825248-24-000018.md) | [388](/filings/0001825248-26-000007.md) | [1,999](/filings/0001825248-25-000022.md) | [1,954](/filings/0001825248-25-000022.md) | [1,947](/filings/0001825248-25-000022.md) | [1,910](/filings/0001825248-26-000024.md) | [1,899](/filings/0001825248-26-000024.md) | [1,853](/filings/0001825248-26-000024.md) | [1,844](/filings/0001825248-25-000022.md) | [1,840](/filings/0001825248-26-000024.md) | [1,832](/filings/0001825248-26-000024.md) | [1,791](/filings/0001825248-26-000024.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [38.5 d](/filings/0001825248-24-000018.md) | [19.1 d](/filings/0001825248-26-000007.md) | [196](/filings/0001825248-25-000008.md) | [(54.5) d](/filings/0001825248-25-000017.md) | [(206) d](/filings/0001825248-25-000022.md) | [(146) d](/filings/0001825248-26-000007.md) | [73.8](/filings/0001825248-26-000017.md) | [(170) d](/filings/0001825248-26-000024.md) | [15.6 d](/filings/0001825248-25-000022.md) | [86.8 d](/filings/0001825248-26-000007.md) | [50.9](/filings/0001825248-26-000017.md) | [(22.5) d](/filings/0001825248-26-000024.md) |
| Dividends paid | $m | [7.8 d](/filings/0001825248-24-000018.md) | [7.9 d](/filings/0001825248-26-000007.md) | [7.9](/filings/0001825248-25-000008.md) | [35.1 d](/filings/0001825248-25-000017.md) | [34.5 d](/filings/0001825248-25-000022.md) | [34.5 d](/filings/0001825248-26-000007.md) | [34.7](/filings/0001825248-26-000017.md) | [35.7 d](/filings/0001825248-26-000024.md) | [30.8 d](/filings/0001825248-25-000022.md) | [30.9 d](/filings/0001825248-26-000007.md) | [25.7](/filings/0001825248-26-000017.md) | [0.0 d](/filings/0001825248-26-000024.md) |
| Share repurchases | $m | [0.0 d](/filings/0001825248-24-000018.md) | [0.0 d](/filings/0001825248-26-000007.md) | not reported | not reported | [1.8 d](/filings/0001825248-25-000022.md) | [0.0 d](/filings/0001825248-26-000007.md) | not reported | not reported | [1.2 d](/filings/0001825248-25-000022.md) | [0.1 d](/filings/0001825248-26-000007.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.5](/filings/0001825248-23-000014.md) | [24.6](/filings/0001825248-24-000011.md) | [25.5](/filings/0001825248-24-000014.md) | [25.7](/filings/0001825248-24-000018.md) | [101](/filings/0001825248-25-000008.md) | [135](/filings/0001825248-25-000017.md) | [135](/filings/0001825248-25-000022.md) | [136](/filings/0001825248-26-000017.md) | [135](/filings/0001825248-26-000024.md) | [134](/filings/0001825248-25-000022.md) | [135](/filings/0001825248-26-000017.md) | [135](/filings/0001825248-26-000024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 133,826,844 at 2026-08-06, from the cover of the [10-Q filed 2026-08-12](/filings/0001825248-26-000024.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.